Treatment of generalized convulsive status epilepticus: An international survey in the East Mediterranean Countries. (May 2020)

• Record Type: Journal Article
• Authors: Farhat, Sahar; Nasreddine, Wassim; Alsaadi, Taoufik; Beydoun, Adnan A; Arabi, Maher; Beydoun, Ahmad
• Is Part Of: Seizure. Volume 78(2020)
• Page Start: 96
• Page End: 101
• Publication Date: 2020-05
• Subjects: Generalized convulsive status epilepticus -- ILAE -- survey -- treatment; Epilepsy -- Periodicals; Epilepsy -- Periodicals; Seizures -- Periodicals; Épilepsie -- Périodiques; Electronic journals; Electronic journals; 616.853
• DOI: 10.1016/j.seizure.2020.03.016
• Languages: English
• ISSNs: 1059-1311

Abstract

Abstract: Purpose: Three Chapters of the Commission of the East Mediterranean Affairs (CEMA) of the ILAE conducted a survey to assess the availability of drugs used for the treatment of generalized convulsive status epilepticus (GCSE) across the CEMA countries and to evaluate the treatment choices of adult and pediatric neurologists for the treatment of this condition. Method: The web-based survey consisted of two similar vignettes of GCSE in a child and an adult. The questions evaluated the sequential drugs of choice based on drug availability and with the assumption that all drugs were at the disposition of the neurologists. The neurologists were also asked about the timing of introduction of anesthetic drugs and how they monitor patients in drug induced coma. Results: Our data showed that the availability of drugs differ substantially across CEMA countries. A benzodiazepine and phenytoin/phenobarbital were the initial drugs of choice for the majority of adults and pediatric neurologists. In cases of refractory status, most neurologists would use a third agent before proceeding to treatment with an anesthetic agent. Although the vast majority would prefer to monitor patients in drug-induced coma with continuous EEG, only 38% are using this modality because of its unavailability at their institutions. Conclusions: Our data emphasize that an algorithm for the treatment of GCSE in the CEMA countries should be flexible and should propose different treatment options at each step of the protocol that are based on the best available data while taking into consideration the drug availability across the CEMA countries.